FDA’s BesafeRx Campaign “BeSafeRx: Your Source for Online Pharmacy Information” is a national campaign to educate consumers and health care professionals about the potential dangers of […]

Delivery Method: Via Email Reference #: 320-25-42 Product: Drugs Recipient: Recipient Name Mr. Jorge D. Abraldes Recipient Title CEO ABR Laboratory LLC 450 N Park Rd, […]

Delivery Method: VIA UPS Reference #: 320-25-36 Product: Drugs Recipient: Recipient Name Ms. Ijyahu Raphe Eze Recipient Title Owner AmWiner & Raphe Holdings, LLC dba rapheGenerics […]

Delivery Method: Via Email Reference #: 320-25-41 Product: Drugs Recipient: Recipient Name Mr. Sandeep Gokaraju Recipient Title Owner and Director Tyche Industries Ltd 6-223, Sarpavaram (V)Kakinada […]

Delivery Method: Via Email Reference #: 320-25-39 Product: Drugs Recipient: Recipient Name Mr. Manish Gupta Recipient Title Managing Director Jagsonpal Pharmaceuticals Limited Plot No. 412-415, Phase-IVUdyog […]

Delivery Method: VIA Electronic Mail Reference #: 320-25-43 Product: Drugs Recipient: Recipient Name Mr. Vick Maharaj Recipient Title Chief Executive Officer Marshalls Traditional Healthcare CC 560 […]

On February 14, 2025, the Food and Drug Administration approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cell […]

For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of […]

Summary Company Announcement Date: February 13, 2025 FDA Publish Date: February 14, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Bags of POTASSIUM CHLORIDE […]